title: Slit diaphragm protein Neph1 and its signaling: a novel therapeutic target for protection of podocytes against glomerular injury.
abstract: Podocytes are specialized epithelial cells that are critical components of the glomerular filtration barrier, and their dysfunction leads to proteinuria and renal failure. Therefore, preserving podocyte function is therapeutically significant. In this study, we identified Neph1 signaling as a therapeutic target that upon inhibition prevented podocyte damage from a glomerular injury-inducing agent puromycin aminonucleoside (PAN). To specifically inhibit Neph1 signaling, we used a protein transduction approach, where the cytoplasmic domain of Neph1 (Neph1CD) tagged with a protein transduction domain trans-activator of transcription was transduced in cultured podocytes prior to treatment with PAN. The PAN-induced Neph1 phosphorylation was significantly reduced in Neph1CD-transduced cells; in addition, these cells were resistant to PAN-induced cytoskeletal damage. The biochemical analysis using subfractionation studies showed that unlike control cells Neph1 was retained in the lipid raft fractions in the transduced cells following treatment with PAN, indicating that transduction of Neph1CD in podocytes prevented PAN-induced mislocalization of Neph1. In accordance, the immunofluorescence analysis further suggested that Neph1CD-transduced cells had increased ability to retain endogenous Neph1 at the membrane in response to PAN-induced injury. Similar results were obtained when angiotensin was used as an injury-inducing agent. Consistent with these observations, maintaining high levels of Neph1 at the membrane using a podocyte cell line overexpressing chimeric Neph1 increased the ability of podocytes to resist PAN-induced injury and PAN-induced albumin leakage. Using a zebrafish in vivo PAN and adriamycin injury models, we further demonstrated the ability of transduced Neph1CD to preserve glomerular function. Collectively, these results support the conclusion that inhibiting Neph1 signaling is therapeutically significant in preventing podocyte damage from glomerular injury.
authors.affiliation: From the Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, Pennsylvania 19104 and.
authors.forename: Ehtesham
authors.initials: E
authors.lastname: Arif
authors.forename: Yogendra S
authors.initials: YS
authors.lastname: Rathore
authors.forename: Babita
authors.initials: B
authors.lastname: Kumari
authors.forename: Fnu
authors.initials: F
authors.lastname: Ashish
authors.forename: Hetty N
authors.initials: HN
authors.lastname: Wong
authors.forename: Lawrence B
authors.initials: LB
authors.lastname: Holzman
authors.forename: Deepak
authors.initials: D
authors.lastname: Nihalani
mesh_terms: D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000494:pharmacology; D002460:Cell Line; D050533:Glomerular Basement Membrane / Q000293:injuries* / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D021962:Membrane Microdomains / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism*; D010766:Phosphorylation / Q000235:genetics; D050199:Podocytes / Q000378:metabolism* / Q000473:pathology; D011692:Puromycin Aminonucleoside / Q000009:adverse effects / Q000494:pharmacology; D015027:Zebrafish / Q000235:genetics / Q000378:metabolism*; D029961:Zebrafish Proteins / Q000235:genetics / Q000378:metabolism*
chemical_list: D000964:Antimetabolites, Antineoplastic; C431137:KIRREL1 protein, human; D008565:Membrane Proteins; D029961:Zebrafish Proteins; D011692:Puromycin Aminonucleoside
keywords: Actin; Cell Signaling; Kidney; Neph1; Phosphorylation; Podocytes; Renal Injury